Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases

BioDrugs(2024)10.1007/s40259-024-00667-0Source: DataRank Database

Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases is a research paper published in BioDrugs (2024). On theSindex it has a DataRank of 0.457. It has been cited 20 times.

N/A

0.457DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 5.29)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.457

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (3)

Neelan S Sivaneri,Peter M. Tessier ORCID,John S. Schardt ORCID

Live enrichment

PubMed:38954386 PMC:PMC11645890 OpenAlex:https://openalex.org/W4400226900

National Institute of General Medical Sciences

Grant: R35GM136300

National Institute on Aging

Grant: R01AG080016

National Institute of Neurological Disorders and Stroke

Grant: R21NS132018

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Grant: R21AI171844

NIGMS NIH HHS

Grant: F32 GM137513

National Institutes of Health

Grant: 5R21NS132018-02

Neuronal Silencing of ATXN3 Using Peripherally Administered Antibody/ASO Conjugates That Penetrate the Blood-Brain Barrier

National Institutes of Health

Grant: 5R21AI171844-02

Mutational Analysis of Tradeoffs between Receptor Affinity and Antibody Escape for SARS-CoV-2 Variants of Concern

National Institutes of Health

Grant: 5R35GM136300-04

Structure-guided antibody targeting of pre-selected epitopes in amyloidogenic aggregates

National Institutes of Health

Grant: 1F32GM137513-01

Activity-based discovery and optimization of agonist antibodies

National Institutes of Health

Grant: 5R01AG080016-02

CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease

FWCI

5.29

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc

journalhttps://link.springer.com/content/pdf/10.1007/s40259-024-00667-0.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s40259-024-00667-0.pdf

publisherhttps://link.springer.com/article/10.1007/s40259-024-00667-0/fulltext.html

journalhttps://doi.org/10.1007/s40259-024-00667-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38954386

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchBiosensors and Analytical DetectionCAR-T cell therapy research0303 health sciences03 medical and health sciencesHumansAntibodies, MonoclonalB-LymphocytesCOVID-19SARS-CoV-2AnimalsSingle-Cell AnalysisAntibodies, NeutralizingCommunicable DiseasesCOVID-19 Drug Treatment

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAnimalsAntibodies, MonoclonalB-LymphocytesCommunicable DiseasesHumansAntibodies, NeutralizingSingle-Cell Analysis

Keywords

Monoclonal antibodyInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)DiseasePandemicAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Computational biologyMedicineVirologyImmunologyBiologyB-LymphocytesSARS-CoV-2HumansAntibodies, MonoclonalCOVID-19AnimalsLeading ArticleSingle-Cell AnalysisAntibodies, NeutralizingCommunicable DiseasesCOVID-19 Drug Treatment